[3H] cocaine labels a binding site associated with the serotonin transporter in guinea pig brain: allosteric modulation by paroxetine
- PMID: 1461373
- DOI: 10.1007/BF00968412
[3H] cocaine labels a binding site associated with the serotonin transporter in guinea pig brain: allosteric modulation by paroxetine
Abstract
We studied the characteristics of [3H]cocaine binding to membranes prepared from whole guinea pig brain. Cocaine binding was specific and saturable. A one-site binding model fit the data adequately: the Kd value of [3H]cocaine was 44 nM with a Bmax value of 280 fmol/mg protein. The rank order of potency for the [3H]cocaine binding site was paroxetine > clomipramine > (-)-cocaine > fluoxetine > mazindol > desipramine > GBR12909 > phencyclidine > benztropine > GBR12935 > (+)-cocaine. The IC50 values of these drugs for inhibition of [3H]cocaine binding were highly correlated with their IC50 values for inhibition of [3H]5-HT uptake into synaptosomes prepared from whole guinea pig brain. High affinity 5-HT uptake inhibitors produced dose-dependent wash-resistant (pseudoirreversible) inhibition of [3H]cocaine binding. The wash-resistant inhibition produced by paroxetine was due to an increase in the Kd of [3H]cocaine binding sites, and was accompanied by an increase in the dissociation rate, consistent with an allosteric mechanism. These studies suggest that, using membranes prepared from whole guinea pig brain, [3H]cocaine labels a binding site associated with serotonin transporter and that paroxetine and cocaine bind to different sites on the serotonin transporter.
Similar articles
-
Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate.J Pharmacol Exp Ther. 1995 Jul;274(1):385-95. J Pharmacol Exp Ther. 1995. PMID: 7616423
-
Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.J Pharmacol Exp Ther. 1994 Jul;270(1):296-309. J Pharmacol Exp Ther. 1994. PMID: 8035327
-
Characterization of serotonin transporter in goldfish retina by the binding of [3H]paroxetine and the uptake of [3H]serotonin: modulation by light.J Neurochem. 1994 Feb;62(2):528-35. doi: 10.1046/j.1471-4159.1994.62020528.x. J Neurochem. 1994. PMID: 8294915
-
Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization.J Neurochem. 1994 Feb;62(2):549-56. doi: 10.1046/j.1471-4159.1994.62020549.x. J Neurochem. 1994. PMID: 8294917
-
Neuropharmacology of paroxetine.Psychopharmacol Bull. 2003 Spring;37 Suppl 1:8-18. Psychopharmacol Bull. 2003. PMID: 14566196 Review.
Cited by
-
A fluorescence displacement assay for antidepressant drug discovery based on ligand-conjugated quantum dots.J Am Chem Soc. 2011 Nov 9;133(44):17528-31. doi: 10.1021/ja204301g. Epub 2011 Oct 17. J Am Chem Soc. 2011. PMID: 21970724 Free PMC article.
-
Studies of the biogenic amine transporters. 13. Identification of "agonist" and "antagonist" allosteric modulators of amphetamine-induced dopamine release.J Pharmacol Exp Ther. 2009 May;329(2):718-28. doi: 10.1124/jpet.108.149088. Epub 2009 Feb 24. J Pharmacol Exp Ther. 2009. PMID: 19244097 Free PMC article.
-
Studies of the biogenic amine transporters. 1. Dopamine reuptake blockers inhibit [3H]mazindol binding to the dopamine transporter by a competitive mechanism: preliminary evidence for different binding domains.Neurochem Res. 1994 Feb;19(2):201-8. doi: 10.1007/BF00966817. Neurochem Res. 1994. PMID: 8183430
-
The persistent membrane retention of desipramine causes lasting inhibition of norepinephrine transporter function.Neurochem Res. 2004 Feb;29(2):419-27. doi: 10.1023/b:nere.0000013747.04964.46. Neurochem Res. 2004. PMID: 15002740
-
Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor binding.Neurochem Res. 1994 Sep;19(9):1159-63. doi: 10.1007/BF00965150. Neurochem Res. 1994. PMID: 7824069